Skip to main content
Molecules logoLink to Molecules
. 2021 May 17;26(10):2979. doi: 10.3390/molecules26102979

Photophysical Study and Biological Applications of Synthetic Chalcone-Based Fluorescent Dyes

Sirilak Wangngae 1, Kantapat Chansaenpak 2, Jukkrit Nootem 2, Utumporn Ngivprom 1,3, Sirimongkon Aryamueang 1, Rung-Yi Lai 1,3,*, Anyanee Kamkaew 1,*
Editor: Ivo Piantanida
PMCID: PMC8156934  PMID: 34067859

Abstract

A chalcone series (3af) with electron push–pull effect was synthesized via a one-pot Claisen–Schmidt reaction with a simple purification step. The compounds exhibited strong emission, peaking around 512–567 nm with mega-stokes shift (∆λ = 93–139 nm) in polar solvents (DMSO, MeOH, and PBS) and showed good photo-stability. Therefore, 3af were applied in cellular imaging. After 3 h of incubation, green fluorescence was clearly brighter in cancer cells (HepG2) compared to normal cells (HEK-293), suggesting preferential accumulation in cancer cells. Moreover, all compounds exhibited higher cytotoxicity within 24 h toward cancer cells (IC50 values ranging from 45 to 100 μM) than normal cells (IC50 value >100 μM). Furthermore, the antimicrobial properties of chalcones 3af were investigated. Interestingly, 3af exhibited antibacterial activities against Escherichia coli and Staphylococcus aureus, with minimum bactericidal concentrations (MBC) of 0.10–0.60 mg/mL (375–1000 µM), suggesting their potential antibacterial activity against both Gram-negative and Gram-positive bacteria. Thus, this series of chalcone-derived fluorescent dyes with facile synthesis shows great potential for the development of antibiotics and cancer cell staining agents.

Keywords: chalcones, fluorescence imaging, mega-stokes shift dye, bioimaging, antibacterial

1. Introduction

Chalcones, α,β-unsaturated aromatic ketones, constitute the central skeleton of many important biological compounds [1] and are the biosynthetic precursors of flavonoids and isoflavonoids in plants [2,3]. Their diverse structures can cyclize to form various flavonoid compounds with different biological activities [4,5]. In the past decades, many synthetic analogues, such as aza-chalcones and chalcone derivatives containing isoxazole, pyrazole, and indole, [6] were developed and have shown interesting biological properties, such as antioxidant, anticancer, antimicrobial, antiprotozoal, antiulcer, antiviral, antihistaminic, anti-HIV, cytotoxic, and anti-inflammatory activities [7,8,9]. Moreover, chalcones with a suitable electron push–pull arrangement of functional groups were reported to exhibit bright fluorescence [10,11,12,13] (Figure 1), which is applicable for bioimaging. However, their photophysical and photochemical properties have not been systematically investigated for biological applications [14,15].

Figure 1.

Figure 1

Structural design of chalcone-based fluorescent dyes.

We are particularly interested in exploring chalcones with fluorescent properties and use them for biological applications, such as cellular imaging and microorganism targeting. To achieve these goals, the development of chalcone-based fluorescent dyes with mega-stokes shifts and high photo-stability is important [16,17]. First, a mega-stokes shift (>100 nm) is an essential factor for bioimaging because it can provide a better signal-to-noise fluorescence [18,19]. Some commonly used fluorescent dyes, such as fluorescein [20], rhodamine [21], cyanine [22], nile red [23], and BODIPY [19,24], exhibit small stokes shifts (∆λ < 70 nm) [20,21], which allow them to re-absorb the emitted photons, leading to undesired background interference [25]. Photo-stability is another important parameter to evaluate for practical bioimaging applications of fluorescent dyes.

Some chalcone-based fluorescent compounds have been evaluated to have good photophysical properties [26,27,28,29], and some showed promising results in biological applications. For example, the diamino-chalcone library was discovered to comprise fluorescent probes for mouse embryonic stem cells, targeting glycoproteins on stem cell surface [13]. Cyclic chalcone analogs of ciproxifan with a tetralone motif were synthesized and evaluated as fluorescent ligands for human histamine H3 receptors (hH3R). The ligand affinities were in the nanomolar concentration range, which opens new possibilities for non-radioactive visualization in pharmacological analysis [30]. In addition, another chalcone-based fluorescent probe (carbazole–chalcone) was synthesized for thiophenol detection. It showed good performance in the analysis of real water samples and living cells, since it showed low cytotoxicity [31].

Previously, the 4-dimethylamino group has been proposed as a good donor group for enhanced fluorescence via push–pull effects in the chalcone structure [32,33,34,35]. However, various functional groups at the other end of the chalcone structure have not yet been systematic studied for their photophysical properties and biological application [35]. The good donor ability of a 4-dialkylamino group on one ring together with suitable electronic properties of the other ring substituents, as well as the planar conformation of the core structure, would be essential for optimal fluorescence.

In this study, a series of chalcone derivatives, 3af, was synthesized by one-pot Chaisen–Schmidt reactions using 4-dimethylaminobenzaldehydes and acetophenones with different electron-donating groups at the para-position or 2-acetylthiophene. All synthesized chalcone derivatives resulted soluble in phosphate-buffered saline (PBS) containing 3% Tween 80, which is suitable for biological applications. Their fluorescence spectra showed large stokes shifts (∆λ = 93–139 nm), which could be useful for bioimaging. Therefore, the chalcones 3af were applied in imaging of normal cells (human embryonic kidney 293, HEK-293) and cancer cells (human hepatocellular carcinoma, HepG2). Both cell lines are commonly used in research because they are easy to handle and suitable for various types of assays [36,37]. Moreover, the antimicrobial properties of 3af were also tested against a Gram-negative bacterium (Escherichia coli) and a Gram-positive bacterium (Staphylococcus aureus), which are common members of the human microbiota but can act as opportunistic pathogens and cause disease.

2. Results and Discussion

2.1. Synthesis of Chalcones 3af

The structure of chalcones 3af [38,39,40,41] was designed to allow synthesis from various aromatic ketones (1) and an aldehyde (2), both containing electron-donating groups to push electron towards the carbonyl group of the resulting chalcones. 4-Dimethylaminobenzaldehyde 2 was chosen as the aldehyde, because it was reported to have good donor ability. Furthermore, the substituents of the aromatic ketone 1 varied so to observe their effects on the photophysical properties. The chalcones 3af were synthesized via one-pot Claisen–Schmidt reaction (Scheme 1), according to a previously published method [41]. The substrates 1 with various para-substituted acetophenone or 2-acetylthiophene moieties were reacted with 4-dimethylaminobenzaldehyde 2 to generate chalcones 3af with good yields (70–88%) after filtration, without column purification. The chalcones 3af were analyzed by 1H-NMR, 13C-NMR, and HRMS (in ESI).

Scheme 1.

Scheme 1

Synthesis of chalcones 3af via the Claisen–Schmidt reaction.

2.2. Photophysical Properties of Chalcones 3af

The absorbance and fluorescence spectra of chalcones 3af were measured in DMSO, MeOH, and PBS containing 3% Tween 80. All compounds in DMSO exhibited the maximum absorbance at wavelengths ranging from 412 to 431 nm (Figure 2 and Table 1). Similar absorbance profiles were also observed in the protic solvents MeOH and PBS (Table 1 and Figures S1 and S2 in Supplementary Materials). Notably, all compounds in every solvent showed mega-stokes shifts ranging from 93 to 139 nm, with fluorescent emission wavelengths ranging from 512 to 567 nm. These mega-stokes shifts are beneficial for bioimaging applications because they could reduce self-quenching resulting from molecular self-absorption. Moreover, the fluorescent quantum yields (Φf) of chalcones 3af in the polar aprotic solvent (i.e., DMSO) were higher than those in polar protic solvents (i.e., MeOH and PBS).

Figure 2.

Figure 2

Normalized absorption and fluorescence spectra of chalcones 3af in DMSO. Fluorescence spectra with the excitation wavelength at the absorption maximum of each compound.

Table 1.

Photophysical properties of chalcone 3af (2 µM) in different solvents.

Solvents Dye Photophysical Properties
λabs a
(nm)
λem b
(nm)
∆λ c
(nm)
Φf d
(n = 3)
ε e
(M−1 cm−1)
DMSO 3a 417 532 115 0.69 ± 0.04 4.6 × 104
3b 431 560 129 0.34 ± 0.04 3.1 × 104
3c 413 520 107 0.61 ± 0.04 1.0 × 104
3d 422 516 94 0.10 ± 0.02 4.6 × 104
3e 420 539 119 0.50 ± 0.02 3.2 × 104
3f 412 512 100 0.21 ± 0.03 3.5 × 104
MeOH 3a 417 549 132 0.013 ± 0.006 3.0 × 104
3b 428 567 139 0.012 ± 0.007 2.9 × 104
3c 414 546 132 0.017 ± 0.011 1.0 × 104
3d 423 555 132 0.024 ± 0.015 3.7 × 104
3e 417 547 130 0.012 ± 0.007 3.2 × 104
3f 414 549 135 0.027 ± 0.011 3.1 × 104
PBS
(3%w/w tween 80)
3a 416 529 113 0.15 ± 0.02 3.3 × 104
3b 427 520 93 0.11 ± 0.02 3.7 × 104
3c 411 526 115 0.11 ± 0.02 1.3 × 104
3d 422 542 120 0.17 ± 0.03 4.4 × 104
3e 420 521 101 0.18 ± 0.03 2.8 × 104
3f 412 524 112 0.18 ± 0.02 3.4 × 104

a λabs = absorption maximum wavelength, b λem = emission maximum wavelength (excited at the maximum absorption wavelength), c ∆λ = stokes shifts (λem − λabs), d Φf = fluorescence quantum yields calculated by using fluorescein in 0.1 M NaOH as a standard (Φf = 0.95). e ε = molar absorptivity.

2.3. pH Effects of Chalcones 3af by Fluorescence Spectroscopic Analysis

Since the chalcones 3af contain a dimethylamino (-NMe2) group that could form different charge states at different pH [42,43], we postulated that this phenomenon could change the photophysical properties of our chalcones. Therefore, to observe changes in the optical property of chalcones 3af under different pH, the emission spectra of 3af were recorded at various pH values ranging from 1.04 to 11.90 (Figure 3). The spectral analysis indicated that all chalcones (3af) showed decreasing fluorescent signals in highly acidic conditions (pH 1), indicating that the dimethylamino moiety (NMe2) was fully protonated. Higher emission peaks were observed over a wide pH range from 2 to 12 for chalcones 3a, 3b, 3d, 3e, and 3f, suggesting that the electron push–pull effect from the dimethylamino to the carbonyl group was preserved (Figure 3A,B,D–F). On the other hand, chalcone 3c, which contains a hydroxyl group (-OH), showed reduced emission signals in basic conditions (pH 9–12) (Figure 3C). This phenomenon could result from the deprotonation of the phenolic proton to generate a phenoxide ion, whose electron can delocalize to the carbonyl group, which would alter the electron flow direction of the compound. Based on these results, all chalcone derivatives sustained their strong fluorescence signals over a wide pH range, which is suitable for cell imaging experiments.

Figure 3.

Figure 3

Fluorescence spectra of 3a (A), 3b (B), 3c (C), 3d (D), 3e (E), and 3f (F) in pH 1.04–11.90 buffers.

2.4. Photostability of Chalcones 3af

The photostability of chalcones 3af against photobleaching was assessed in DMSO (Figure 4). In this experiment, each chalcone derivative was exposed to irradiation with 250 W blue light (380–500 nm) in an air-saturated condition for 30 min. The photostability was monitored by UV–Vis (Figure 4A) and fluorescence (Figure 4B) spectrophotometry. After 1 min irradiation, the maximum absorbance of all compounds, except for 3b, dropped dramatically. However, when the exposure time was prolonged from 5 to 30 min, all compounds (3af) showed the minimal loss in the maximum absorbance and emission, suggesting that the compounds are quite stable under blue light irradiation for up to at least 30 min. The decrease in absorbance and fluorescence intensities (% photobleaching) of chalcones 3af was also determined based on the difference between the areas under the absorption and emission spectra of chalcones 3af before and after photobleaching (Figure S4 in Supplementary Materials). By this method, the calculated percentages of photobleaching of absorbance (after 30 min irradiation, Figure S4A in Supplementary Materials) of 3af in DMSO were found to be 50%, 26%, 37%, 51%, 46%, and 48%, respectively. Figure S4B (in Supplementary Materials) shows the calculated % photobleaching of fluorescence (after 30 min irradiation) of 3af in DMSO (25%, 43%, 50%, 30%, 21%, and 47%, respectively).

Figure 4.

Figure 4

Photobleaching studies at 250 W blue light monitored at the maximum absorbance (A) and emission intensity (B) of chalcones 3af in DMSO.

2.5. Cell Viability

Next, the cellular toxicity of chalcones 3af was tested in two cell lines, i.e., normal (HEK-293) and cancer (HepG2) cells. The cells were treated with various concentrations of 3af (0, 1, 5, 10, 20, 50, and 100 μM) for 24 h. The comparative cell viability was determined by MTT assays. As shown in Figure 5A, the normal cells retained more than 80% viability at concentrations up to 20 μM, whereas at the high concentration (50 μM), the viability of the cells dropped to about 60%. For the cancer cells, similar cytotoxicity profiles of 3af were observed. However, the cell viability was dramatically reduced to about 40% at the concentration of 50 μM (Figure 5B). In addition, the chalcones (3af) were determined to have IC50 values of 45–100 µM for HepG2 and >100 µM for HEK-293 cells (Table 2 and Figure S6 in Supplementary Materials). Therefore, the examined cancer cells seem to be more sensitive to our tested compounds than the normal cells, as the IC50 values were about 2–3 times lower for each compound. These results are comparable with those of previous anti-cancer activity studies of chalcone series, some of which showed good activity towards cancer cells [38,44,45].

Figure 5.

Figure 5

Cytotoxicity effect of chalcones 3af on the cellular viability of HEK-293 (A) and HepG2 (B). All cells were treated with chalcones 3af at different concentrations for 24 h (error bar represents standard deviation, n = 3). Statistical analysis is based on one-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001).

Table 2.

IC50 of the chalcones (3af).

Cell Lines IC50 (μM)
3a 3b 3c 3d 3e 3f
HEK-293 >100 >100 >100 >100 96 >100
HepG2 56 45 100 56 54 54

2.6. Confocal Imaging

As 3af exhibited bright fluorescence with mega-strokes shifts, their application in live cell imaging was explored. The cancer cells HepG2 were incubated with 3af (5 μM) for 1–3 h and then washed thoroughly with PBS before being imaged by a confocal laser scanning microscope (CLSM). The cells incubated with chalcones 3af exhibited bright green fluorescence at every time point compared with the control cells (no compound added, Figure 6). The imaging was also performed with the normal cells (HEK-293) using the same treatment. However, the quantitative data did not show significant difference between the green emission from the compounds and that from cell autofluorescence (Figure S5 in Supplementary Materials). In summary, these results suggest that our chalcone derivatives could be used as cancer cell staining probes.

Figure 6.

Figure 6

(A) CLSM images of HepG2 cells incubated with 5 μM of chalcones 3af for 1–6 h. Scale bar = 20 µm. (B) Corrected total cell fluorescence data quantified using ImageJ and represent the mean ± SD (n = 30).

2.7. Antibacterial Activity of the Synthesized Chalcones (3af)

Lastly, the antibacterial activities of chalcones 3af were evaluated in Gram negative bacteria (E. coli 780) and Gram-positive bacteria (S. aureus 1466). The MIC and MBC values of chalcone 3af for E. coli 780 ranged from 250 to 375 μM and from 375 to 1000 μM, respectively (Table 3). For S. aureus 1466, the MIC values of 3af ranged from 250 to 375 μM, which is similar to that for E. coli 780 (Table 3), whereas the MBC values were much higher (1000 μM). The greater antibacterial activities of chalcones against E. coli 780 than S. aureus 1466 might be due to the thinness of the peptidoglycan layer in Gram-negative bacteria [28,46,47,48]. According to the MIC and MBC values, 3d showed the best antimicrobial activities against E. coli 780 and S. aureus 1466 compared to the other compounds among the series. Therefore, the growth curves of E. coli 780 and S. aureus 1466 in the presence of various concentrations of 3d were obtained by optical density at 600 nm (OD600) for 24 h (Figure 7). As the concentration of 3d increased, the growth of both bacteria strains was significantly inhibited. The data of all antibacterial experiments are presented in Figures S7 and S8 in Supplementary Materials. The inhibitory results are not as good as those previously reported for chalcones with extra modifications [46].

Table 3.

Antibacterial activities of the compounds 3af.

Compounds E. coli 780 S. aureus 1466
MIC (μM) MBC (μM) MIC (μM) MBC (μM)
3a 375 ± 0.01 750 ± 0.02 375 ± 0.03 1000 ± 0.09
3b 250 ± 0.02 750 ± 0.02 375 ± 0.01 1000 ± 0.01
3c 250 ± 0.01 750 ± 0.01 375 ± 0.01 1000 ± 0.01
3d 250 ± 0.01 375 ± 0.01 250 ± 0.01 1000 ± 0.01
3e 375 ± 0.01 1000 ± 0.02 375 ± 0.03 1000 ± 0.02
3f 375 ± 0.01 750 ± 0.01 375 ± 0.01 1000 ± 0.04

MIC and MBC values are indicated as the mean ± SD (standard deviation) of three independent experiments.

Figure 7.

Figure 7

Growth curves of E. coli 780 (A) and S. aureus 1466 (B) in response to 3d in a time course of 24 h.

The recent findings on structure–activity relationships (SAR) in medicinal chemistry showed that halogenated chalcones (i.e., fluorine or chlorine-substituted chalcones) have better antibacterial activity. Moreover, some hybrid structures, such as ferrocene–chalcone hybrids or steroidal–chalcone hybrids also exhibit potent antibacterial activities. Alternatively, replacing a 4-dimethylamino group with other electron-donating groups, such as -OH or -OMe, or with electron-withdrawing groups (-Cl, -Br, -I, or -NO2), as well as other heterocyclic substituents, would alter the antibacterial activity [46]. These findings suggest that additional structural optimization of chalcone derivatives is necessary for the development of potential antimicrobial drugs.

3. Materials and Methods

3.1. Material and Instrumentation

The 1H- and 13C-NMR data were collected on a Bruker 500 MHz NMR (Bruker Ltd., Rheinstetten, Germany) in CDCl3, DMSO-d6, and acetone-d6 as solvents at room temperature, with tetramethylsilane (TMS) as an internal reference. High-resolution mass spectra (HRMS) were recorded by an electrospray ionization mass (ESI-MS) spectrometer (MicrOTOF, Bruker, Rheinstetten, Germany). The absorbance and fluorescence spectra were measured on a UV–Vis spectrophotometer (Agilent Technologies Cary 300, CA, USA) and a fluorescence spectrophotometer (PerkinElmer LS55, MA, USA), respectively. All glassware was oven-dried prior to use. All reagents and solvents were purchased from the companies Sigma Aldrich and Merck (MO, USA), TCI (Tokyo, Japan), or Carlo Erba (Barcelona, Spain)and used without further purification. Analytical thin-layer chromatography (TLC) was performed on TLC Silica gel 60 F254 (Merck, MO, USA) and visualized under a UV cabinet lamp.

3.2. Synthesis

The general synthetic procedure for chalcones 3af is shown in Scheme 1. A substituted aromatic/heteroaromatic acetophenone (1) (0.67 mmol) was mixed with 4-dimethylaminobenzaldehydes (2) (100 mg, 0.67 mmol) in MeOH (2 mL) containing KOH (188 mg, 3.35 mmol). The mixture was stirred for 18 h at 25 °C to yield a precipitate as a product. The solid was filtered out, washed with cold MeOH (20 mL), and finally dried under vacuum. The pure products were obtained as the corresponding chalcones (3af) in 70–88% yield.

3.3. Photophysical Properties

All UV–Vis absorption and fluorescence spectra were recorded on a UV–Vis Spectrophotometer (Agilent Technologies Cary 300, Santa Clara, CA, USA) and a Spectrofluorometer (PerkinElmer LS55, Waltham, MA, USA), respectively. In both experiments, the stock solutions of chalcones 3af were prepared as 0.5 mM in DMSO. The appropriate amount of the stock solution was added to DMSO, MeOH, and 0.01 M PBS buffer (pH 7.4) with 3% Tween 80 (3 mL) to obtain the final concentration of 2 µM in the testing solutions. For fluorescence experiments, the emission spectra were recorded at the maximum absorbance wavelength of each compound. The fluorescent quantum yields (Φf) were calculated relative to fluorescein in 0.1 M NaOH as a standard (Φf = 0.95).

3.4. Study of the Effect of pH

Chalcones 3af (2 µM) were dissolved in commercial pH 1–12 buffers purchased from Merck (St. Louis, MO, USA) (glycine/NaCl/HCl for pH 1, citric acid/NaOH/HCl for pH 2–6, Na2HPO4/KH2PO4 for pH 7, boric acid/ KCl/NaOH for pH 8–11, Na3PO4/NaOH for pH 12) in the presence of Tween 80 (3% w/w). The actual pH values of the final buffer solutions were measured by a pH meter. The resulting solutions were examined by a Spectrofluorometer (PerkinElmer LS55) at the maximum absorbance wavelength of each compound.

3.5. Photo-Stability Test

Chalcones 3af were dissolved in DMSO at the final concentration of 1 × 10−6 M for measuring absorption and emission intensity. Then, 3af were irradiated at 250 W (blue-lamp) at a distance of 75 cm. The UV–Visible absorption and fluorescence spectra of the solutions were measured at different time points including 0, 1, 5, 10, 15, 20, and 30 min. Photo-stability was reported in terms of photobleaching absorption and emission (%) calculated from the change of absorption and emission intensity at the absorption and emission maxima before and after irradiation.

3.6. Confocal Imaging

For fluorescence imaging of living cells, human embryonic kidney 293 (HEK-293, ATCC) and human hepatoma cancer cell (HepG2, ATCC) were cultured in Dulbecco′s Modified Eagle′s Medium (DMEM, HyClone) supplemented with 10% Fetal Bovine Serum (FBS, Gibco, Carlsbad, CA, USA) and 1% Penicillin/Streptomycin Solution 100X (Corning, Corning, NY, USA). All cells were cultured in a humidified incubator at 37 °C with 5% CO2. HEK-293 and HepG2 cells, approximately 1 × 104 cells, were seeded on 8-well chambered cover glasses (LabTek, Nunc, Carlsbad, CA, USA) and incubated in complete medium for 24 h. After that, the cells were treated with 5 μM stock solutions of 3af in DMSO/cell culture medium containing 10% FBS (0.25% DMSO), for 0, 1, 3, and 6 h. Then, the cells were washed twice with 0.01 M PBS before being visualized under a Laser-Scanning Confocal Microscope (Nikon A1Rsi) with a 60× oil immersion objective lens and living cell workstation with the excitation channel at 488 nm.

3.7. Cell Viability Assay

The cells were seeded on a 96-well plate, approximately 7 × 103 cells per well, and incubated in complete medium for 24 h. After that, the cells were treated with 0, 1, 5, 10, 20, and 50 μM of chalcones 3af, and culturing continued for 24 h. After incubation, the cells were washed three times with 10 mM PBS and treated with 20 mL of methylthiazolyldiphenyl-tetrazolium bromide (MTT reagent, 0.5 mg mL−1, Sigma-Aldrich, St. Louis, MO, USA) for 2–3 h. After medium removal, DMSO was added to dissolve the formazan product, and cell viability was determined by UV–Vis absorption of the resulting formazan at a wavelength of 560 nm in a microplate reader (BMG Labtech/SPECTROstar Nano, Ortenberg, Germany).

3.8. Antibacterial Activity Test

All bacteria strains were obtained from the Thailand Institute of Scientific and Technological Research (TISTR). The antibacterial activity of chalcones 3af was determined by the minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC) against the Gram-positive (S. aureus 1466, TISTR 1466) and Gram-negative (E.coli 780, TISTR 780) bacteria [23]. The stocks of chalcones 3af (0.60 mg/mL) were serially diluted in Muller–Hinton (MH) broth to obtain concentrations in the range of 250–1000 µM. The solutions of chalcones 3af (100 µL) at different concentrations were added in the culture of the tested bacteria (100 µL) at a concentration of 1 × 106 colony-forming units/mL (CFU/mL) in MH broth at 37 °C with shaking at 80 rpm. The bacterial numbers were determined by measuring the optical density at 600 nm by a UV–Vis spectrometer. The MIC value was determined at the minimal concentration of the compounds that completely inhibited bacterial growth. To determine the MBC values, the bacterial cultures (10 µL) containing the solutions of chalcones 3af at MIC and three higher concentrations were dropped on MH agar plates. After incubating at 37 °C for 24 h, the MBC value was determined at the minimal concentration of these compounds that killed 100% of the bacterial populations.

4. Conclusions

In summary, we found that chalcones containing a 4-dimethylamino group as a strong electron donor moiety combined with the effect of an electron donor from another aromatic end showed enhanced fluorescent emission via push–pull effects. Their photophysical properties were systematically investigated, revealing that the electron push–pull arrangement in the structures caused UV-Vis absorbance at 350–500 nm and fluorescent emission in the visible region (470–700 nm) with mega-stokes shifts (>100 nm). In addition, the chalcone series exhibited high photo-stability and stability in a wide range of pH, which makes them suitable for biological applications. Therefore, their application in bioimaging and in the analysis of anticancer and antibacterial activities was tested. Chalcones 3af showed significantly higher cytotoxicity against cancer cells (HepG2) than normal cells (HEK-293), with IC50 ranging from 45 to 100 µM and >100 µM, respectively. Moreover, 3af could be used as cancer cell-staining probes that emit green light within a few hours of incubation. Furthermore, the synthesized chalcones exhibited antibacterial activity against both E. coli and S. aureus, suggesting their potential antimicrobial applications after additional chemical modifications. Finally, this study provides a good example of how to synthesize skeleton analogues of natural products through easy steps to generate compounds that possess fluorescence properties for biological applications.

Acknowledgments

James R. Ketudat-Cairns is thanked for proofreading.

Supplementary Materials

The followings are available online. All the synthetic procedures for compounds 3af, Figure S1: Absorption and fluorescence spectra of 3af in PBS and MeOH, Figure S2: The UV–Vis absorption and fluorescence spectra of 3b, 3d, 3e, and 3f at different pH (3, 5, 7, 10, and 12), Figure S3; Absorption and fluorescence spectra of fluorescein in 0.1 M NaOH, Figure S4: Calculated % photobleaching of chalcones 3af in DMSO based on absorbance and fluorescence changes, Figure S5: CLSM images of HEK-293 cells incubated with 5 μM of chalcone 3af for 1–3 h, Figure S6; Plots of concentrations of 3af vs. percent viability of HEK-293 (A) and HepG2 (B) cells, Figure S7: Growth curves of E. coli 780 in response to 3af in a time course of 24 h, Figure S8: Growth curves of S. aureus 1466 in response to 3af in a time course of 24 h. References [38,39,40,41,49] are cited in the Supplementary Materials.

Author Contributions

Conceptualization, A.K. and R.-Y.L.; methodology, S.W., S.A., K.C., J.N., and U.N.; software, S.W.; validation, A.K., R.-Y.L., and K.C.; formal analysis, S.W.; investigation, S.W., K.C., J.N., and U.N.; resources, K.C.; writing—original draft preparation, S.W.; writing—review and editing, A.K., R.-Y.L., and K.C.; visualization, S.W., A.K., K.C., and U.N.; supervision, A.K. and R.-Y.L.; project administration, A.K.; funding acquisition, A.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Suranaree University of Technology (SUT) and by Thailand Science Research and Innovation (TSRI). And The APC was funded by SUT.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article or Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds 3af are available from the authors.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Shin S.P., Choi Y.M., Kim W.H., Hong S.P., Park J.M., Kim J., Kwon O., Lee E.H., Hahm K.B. A double blind, place-bo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant ir-ritable bowel syndrome. J. Clin. Biochem. Nutr. 2018;62:179–186. doi: 10.3164/jcbn.17-73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sahu N.K., Balbhadra S.S., Choudhary J., Kohli D.V. Exploring Pharmacological Significance of Chalcone Scaffold: A Review. Curr. Med. Chem. 2012;19:209–225. doi: 10.2174/092986712803414132. [DOI] [PubMed] [Google Scholar]
  • 3.Batovska D.I., Todorova I.T. Trends in utilization of the pharmacological potential of chalcones. Curr. Clin. Pharmacol. 2010;5:1–29. doi: 10.2174/157488410790410579. [DOI] [PubMed] [Google Scholar]
  • 4.Wang J.-F., Liu S.-S., Song Z.-Q., Xu T.-C., Liu C.-S., Hou Y.-G., Huang R., Wu S.-H. Naturally Occurring Flavonoids and Isoflavonoids and Their Microbial Transformation: A Review. Molecules. 2020;25:5112. doi: 10.3390/molecules25215112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Šamec D., Karalija E., Šola I., Bok V.V., Salopek-Sondi B. The Role of Polyphenols in Abiotic Stress Response: The Influence of Molecular Structure. Plants. 2021;10:118. doi: 10.3390/plants10010118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Luo Y., Song R., Li Y., Zhang S., Liu Z.-J., Fu J., Zhu H.-L. Design, synthesis, and biological evaluation of chalcone oxime derivatives as potential immunosuppressive agents. Bioorganic Med. Chem. Lett. 2012;22:3039–3043. doi: 10.1016/j.bmcl.2012.03.080. [DOI] [PubMed] [Google Scholar]
  • 7.Pilatova M., Varinska L., Perjesi P., Sarissky M., Mirossay L., Solar P., Ostro A., Mojzis J. In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues. Toxicol. Vitr. 2010;24:1347–1355. doi: 10.1016/j.tiv.2010.04.013. [DOI] [PubMed] [Google Scholar]
  • 8.Lavis L.D., Raines R.T. Bright Building Blocks for Chemical Biology. ACS Chem. Biol. 2014;9:855–866. doi: 10.1021/cb500078u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Singh P., Anand A., Kumar V. Recent developments in biological activities of chalcones: A mini review. Eur. J. Med. Chem. 2014;85:758–777. doi: 10.1016/j.ejmech.2014.08.033. [DOI] [PubMed] [Google Scholar]
  • 10.Karuppusamy A., Vandana T., Kannan P. Pyrene based chalcone materials as solid state luminogens with aggrega-tion-induced enhanced emission properties. J. Photochem. Photobiol. A Chem. 2017;345:11–20. doi: 10.1016/j.jphotochem.2017.05.026. [DOI] [Google Scholar]
  • 11.Shanker N., Dilek O., Mukherjee K., McGee D.W., Bane S.L. Aurones: small molecule visible range fluorescent probes suitable for biomacromolecules. J. Fluoresc. 2011;21:2173–2184. doi: 10.1007/s10895-011-0919-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.A Fayed T., Awad M.K. Dual emission of chalcone-analogue dyes emitting in the red region. Chem. Phys. 2004;303:317–326. doi: 10.1016/j.chemphys.2004.06.023. [DOI] [Google Scholar]
  • 13.Lee S.-C., Kang N.-Y., Park S.-J., Yun S.-W., Chandran Y., Chang Y.-T. Development of a fluorescent chalcone library and its application in the discovery of a mouse embryonic stem cell probe. Chem. Commun. 2012;48:6681. doi: 10.1039/c2cc31662e. [DOI] [PubMed] [Google Scholar]
  • 14.Allison R.R., Moghissi K. Photodynamic Therapy (PDT): PDT Mechanisms. Clin. Endosc. 2013;46:24–29. doi: 10.5946/ce.2013.46.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wu X., Sun X., Guo Z., Tang J., Shen Y., James T.D., Tian H., Zhu W. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug. J. Am. Chem. Soc. 2014;136:3579–3588. doi: 10.1021/ja412380j. [DOI] [PubMed] [Google Scholar]
  • 16.Bricks J.L., Kachkovskii A.D., Slominskii Y.L., Gerasov A.O., Popov S.V. Molecular design of near infrared polymethine dyes: A review. Dyes Pigments. 2015;121:238–255. doi: 10.1016/j.dyepig.2015.05.016. [DOI] [Google Scholar]
  • 17.Henary M., Levitz A. Synthesis and applications of unsymmetrical carbocyanine dyes. Dyes Pigments. 2013;99:1107–1116. doi: 10.1016/j.dyepig.2013.08.001. [DOI] [Google Scholar]
  • 18.Panigrahi M., Dash S., Patel S., Mishra B.K. Syntheses of cyanines: A review. Tetrahedron. 2012;68:781–805. doi: 10.1016/j.tet.2011.10.069. [DOI] [Google Scholar]
  • 19.Mora-Huertas C., Fessi H., Elaissari A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010;385:113–142. doi: 10.1016/j.ijpharm.2009.10.018. [DOI] [PubMed] [Google Scholar]
  • 20.Kamaly N., Xiao Z., Valencia P.M., Radovic-Moreno A.F., Farokhzad O.C. Targeted polymeric therapeutic nanoparticles: Design, development and clinical translation. Chem. Soc. Rev. 2012;41:2971–3010. doi: 10.1039/c2cs15344k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Reisch A., Klymchenko A.S. Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for Bioimaging. Small. 2016;12:1968–1992. doi: 10.1002/smll.201503396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yan L., Zhang Y., Xu B., Tian W. Fluorescent nanoparticles based on AIE fluorogens for bioimaging. Nanoscale. 2016;8:2471–2487. doi: 10.1039/C5NR05051K. [DOI] [PubMed] [Google Scholar]
  • 23.Mdee L.K., Yeboah S.O., Abegaz B.M. Rhuschalcones II-VI, five new bichalcones from the root bark of Rhus pyroides. J. Nat. Prod. 2003;66:599–604. doi: 10.1021/np020138q. [DOI] [PubMed] [Google Scholar]
  • 24.Martin A., Long C., Forster R.J., Keyes T.E. Near IR emitting BODIPY fluorophores with mega-stokes shifts. Chem. Commun. 2012;48:5617–5619. doi: 10.1039/c2cc31150j. [DOI] [PubMed] [Google Scholar]
  • 25.Shahverdi A., Fazeli M., Rafii F., Kakavand M., Jamalifar H., Hamedi J. Inhibition of Nitrofurantoin Reduction by Menthol Leads to Enhanced Antimicrobial Activity. J. Chemother. 2003;15:449–453. doi: 10.1179/joc.2003.15.5.449. [DOI] [PubMed] [Google Scholar]
  • 26.Krawczyk P., Pietrzak M., Janek T., Jędrzejewska B., Cysewski P. Spectroscopic and nonlinear optical properties of new chalcone fluorescent probes for bioimaging applications: a theoretical and experimental study. J. Mol. Model. 2016;22:125. doi: 10.1007/s00894-016-2990-4. [DOI] [PubMed] [Google Scholar]
  • 27.Gaber M., Fayed T.A., El-Daly S.A., El-Sayed Y.S. Spectral properties and inclusion of a hetero-chalcone analogue in orga-nized media of micellar solutions and beta-cyclodextrin. Photochem. Photobiol. Sci. 2008;7:257–262. doi: 10.1039/B713381B. [DOI] [PubMed] [Google Scholar]
  • 28.Morão L.G., Lorenzoni A.S.G., Chakraborty P., Ayusso G.M., Cavalca L.B., Santos M.B., Marques B.C., Dilarri G., Zamuner C., Regasini L.O., et al. Investigating the Modes of Action of the Antimicrobial Chalcones BC1 and T9A. Molecules. 2020;25:4596. doi: 10.3390/molecules25204596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fedorowicz J., Sączewski J., Konopacka A., Waleron K., Lejnowski D., Ciura K., Tomašič T., Skok Ž., Savijoki K., Morawska M., et al. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents. Eur. J. Med. Chem. 2019;179:576–590. doi: 10.1016/j.ejmech.2019.06.071. [DOI] [PubMed] [Google Scholar]
  • 30.Tomasch M., Schwed J.S., Weizel L., Stark H. Novel Chalcone-Based Fluorescent Human Histamine H3 Receptor Ligands as Pharmacological Tools. Front. Syst. Neurosci. 2012;6:14. doi: 10.3389/fnsys.2012.00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Liu H., Guo C., Guo S., Wang L., Shi D. Design and Synthesis of a Fluorescent Probe with a Large Stokes Shift for Detecting Thiophenols and Its Application in Water Samples and Living Cells. Molecules. 2019;24:375. doi: 10.3390/molecules24020375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rurack K., Bricks J.L., Reck G., Radeglia A.R., Resch-Genger U. Chalcone-Analogue Dyes Emitting in the Near-Infrared (NIR): Influence of Donor−Acceptor Substitution and Cation Complexation on Their Spectroscopic Properties and X-ray Structure. J. Phys. Chem. A. 2000;104:3087–3109. doi: 10.1021/jp994269k. [DOI] [Google Scholar]
  • 33.Wei Y., Qin G., Wang W., Bian W., Shuang S., Dong C. Development of fluorescent FeIII sensor based on chalcone. J. Lumin- 2011;131:1672–1676. doi: 10.1016/j.jlumin.2011.03.062. [DOI] [Google Scholar]
  • 34.Ibnaouf K., Elzupir A., AlSalhi M., Alaamer A.S. Influence of functional groups on the photophysical properties of dimethylamino chalcones as laser dyes. Opt. Mater. 2018;76:216–221. doi: 10.1016/j.optmat.2017.12.034. [DOI] [Google Scholar]
  • 35.Elzupir A., Ali M., Hussein R., Ibrahem M., Al-Muhanna M.K., Ibnaouf K. Molecular structure, frontier molecular orbital and spectral analysis of dimethylamino chalcones efficient lasing dyes. J. Mol. Struct. 2019;1178:285–289. doi: 10.1016/j.molstruc.2018.10.035. [DOI] [Google Scholar]
  • 36.A Dumont J., Euwart D., Mei B., Estes S., Kshirsagar R.R. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit. Rev. Biotechnol. 2016;36:1110–1122. doi: 10.3109/07388551.2015.1084266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Baquerizo A., Bañares R., Saliba F. Transplantation of the Liver. Elsevier BV; Amsterdam, The Netherlands: 2015. Current Clinical Status of the Extracorporeal Liver Support Devices; pp. 1463–1487. [Google Scholar]
  • 38.Syam S., Abdelwahab S.I., Al-Mamary M.A., Mohan S. Synthesis of Chalcones with Anticancer Activities. Molecules. 2012;17:6179–6195. doi: 10.3390/molecules17066179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kar S., Mishra R.K., Pathak A., Dikshit A., Golakoti N.R., Rao G.N. In silico modeling and synthesis of phenyl and thienyl analogs of chalcones for potential leads as anti-bacterial agents. J. Mol. Struct. 2018;1156:433–440. doi: 10.1016/j.molstruc.2017.12.002. [DOI] [Google Scholar]
  • 40.Bhatia N.M. Solution Phase Combinatorial Synthesis and Screening of Mini Libraries of Arylchalcones for Antibacterial Activity. Sci. Pharm. 2008;76:259–267. doi: 10.3797/scipharm.0803-36. [DOI] [Google Scholar]
  • 41.Prasad Y.R., Rani V.J., Rao A.S. In vitro Antioxidant Activity and Scavenging Effects of Some Synthesized 4¢-Aminochalcones. Asian J. Chem. 2013;25:52–58. doi: 10.14233/ajchem.2013.12441. [DOI] [Google Scholar]
  • 42.Zhou B., Jiang P., Lu J., Xing C. Characterization of the Fluorescence Properties of 4-Dialkylaminochalcones and Investi-gation of the Cytotoxic Mechanism of Chalcones. Arch. Pharm. 2016;349:539–552. doi: 10.1002/ardp.201500434. [DOI] [PubMed] [Google Scholar]
  • 43.Demir Y., Taslimi P., Ozaslan M.S., Oztaskin N., Çetinkaya Y., Gulçin I., Beydemir Ş., Goksu S. Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes. Arch. Pharm. 2018;351:e1800263. doi: 10.1002/ardp.201800263. [DOI] [PubMed] [Google Scholar]
  • 44.Yang J.L., Ma Y.H., Li Y.H., Zhang Y.P., Tian H.C., Huang Y.C., Li Y., Chen W., Yang L.J. Design, Synthesis, and An-ticancer Activity of Novel Trimethoxyphenyl-Derived Chalcone-Benzimidazolium Salts. ACS Omega. 2019;4:20381–20393. doi: 10.1021/acsomega.9b03077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ma X., Wang D., Wei G., Zhou Q., Gan X. Synthesis and anticancer activity of chalcone–quinoxalin conjugates. Synth. Commun. 2021;51:1363–1372. doi: 10.1080/00397911.2021.1881124. [DOI] [Google Scholar]
  • 46.Xu M., Wu P., Shen F., Ji J., Rakesh K. Chalcone derivatives and their antibacterial activities: Current development. Bioorganic Chem. 2019;91:103133. doi: 10.1016/j.bioorg.2019.103133. [DOI] [PubMed] [Google Scholar]
  • 47.Amole K.L., Bello I.A., Oyewale A.O. Synthesis, Characterization and Antibacterial Activities of New Fluorinated Chalcones. Chem. Afr. 2019;2:47–55. doi: 10.1007/s42250-019-00043-4. [DOI] [Google Scholar]
  • 48.Prasad Y.R., Rao A.L., Rambabu R. Synthesis and Antimicrobial Activity of Some Chalcone Derivatives. E-J. Chem. 2008;5:461–466. doi: 10.1155/2008/876257. [DOI] [Google Scholar]
  • 49.Kar S., Adithya K.S., Shankar P., Jagadeesh Babu N., Srivastava S., Nageswara Rao G. Nonlinear optical studies and structure-activity relationship of chalcone derivatives with in silico insights. J. Mol. Struct. 2017;1139:294–302. doi: 10.1016/j.molstruc.2017.03.064. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

Data are contained within the article or Supplementary Materials.


Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES